Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,723 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spatial and clonality-resolved 3D cancer genome alterations reveal enhancer-hijacking as a potential prognostic marker for colorectal cancer.
Kim K, Kim M, Lee AJ, Song SH, Kang JK, Eom J, Kang GH, Bae JM, Min S, Kim Y, Lim Y, Kim HS, Kim YJ, Kim TY, Jung I. Kim K, et al. Among authors: kim yj, kim ty, kim m, kim hs, kim y. Cell Rep. 2023 Jul 25;42(7):112778. doi: 10.1016/j.celrep.2023.112778. Epub 2023 Jul 13. Cell Rep. 2023. PMID: 37453058 Free article.
Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth.
Kim W, Lee S, Kim HS, Song M, Cha YH, Kim YH, Shin J, Lee ES, Joo Y, Song JJ, Choi EJ, Choi JW, Lee J, Kang M, Yook JI, Lee MG, Kim YS, Paik S, Kim HH. Kim W, et al. Among authors: kim yh, kim hh, kim ys, kim hs. Genome Res. 2018 Jan 11;28(3):374-82. doi: 10.1101/gr.223891.117. Online ahead of print. Genome Res. 2018. PMID: 29326299 Free PMC article.
Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB, Kim HS, Jung I, Shin SJ, Beom SH, Chang JS, Koom WS, Kim TI, Hur H, Min BS, Kim NK, Park S, Jeong SY, Baek JH, Kim SH, Lim JS, Lee KY, Ahn JB. Lee JB, et al. Among authors: kim ti, kim sh, kim hs, kim nk. Trials. 2020 Apr 7;21(1):320. doi: 10.1186/s13063-020-04266-6. Trials. 2020. PMID: 32264919 Free PMC article.
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer.
Kim JH, Kim SY, Baek JY, Cha YJ, Ahn JB, Kim HS, Lee KW, Kim JW, Kim TY, Chang WJ, Park JO, Kim J, Kim JE, Hong YS, Kim YH, Kim TW. Kim JH, et al. Among authors: kim yh, kim tw, kim ty, kim sy, kim hs, kim j, kim je, kim jw. Cancer Res Treat. 2020 Oct;52(4):1135-1144. doi: 10.4143/crt.2020.218. Epub 2020 Apr 24. Cancer Res Treat. 2020. PMID: 32340084 Free PMC article. Clinical Trial.
Periodontal disease and cancer risk: A nationwide population-based cohort study.
Kim EH, Nam S, Park CH, Kim Y, Lee M, Ahn JB, Shin SJ, Park YR, Jung HI, Kim BI, Jung I, Kim HS. Kim EH, et al. Among authors: kim bi, kim hs, kim y. Front Oncol. 2022 Aug 23;12:901098. doi: 10.3389/fonc.2022.901098. eCollection 2022. Front Oncol. 2022. PMID: 36081548 Free PMC article.
Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.
Kim HS, Kwon HJ, Jung I, Yun MR, Ahn MJ, Kang BW, Sun JM, Kim SB, Yoon DH, Park KU, Lee SH, Koh YW, Kim SH, Choi EC, Koo DH, Sohn JH, Kim B, Kwon NJ, Yun HJ, Lee MG, Lee JH, Kim TM, Kim HR, Kim JH, Paik S, Cho BC. Kim HS, et al. Among authors: kim sb, kim b, kim sh, kim tm, kim hr, kim jh. Clin Cancer Res. 2015 Feb 1;21(3):544-52. doi: 10.1158/1078-0432.CCR-14-1756. Epub 2014 Nov 25. Clin Cancer Res. 2015. PMID: 25424851 Clinical Trial.
15,723 results
You have reached the last available page of results. Please see the User Guide for more information.